Matthew R. McGrew
Net Worth
Last updated:
What is Matthew R. McGrew net worth?
The estimated net worth of Mr. Matthew R. McGrew is at least $117,067,683 as of 11 Nov 2022. He owns shares worth $55,722,351 as insider, has earned $31,825,332 from insider trading and has received compensation worth at least $29,520,000 in Danaher Corporation and Danaher Corporation.
What is the salary of Matthew R. McGrew?
Mr. Matthew R. McGrew salary is $2,460,000 per year as Chief Financial Officer & Executive Vice President in Danaher Corporation. He also receives $2,460,000 as Chief Financial Officer & Executive Vice President in Danaher Corporation.
How old is Matthew R. McGrew?
Mr. Matthew R. McGrew is 53 years old, born in 1972.
What stocks does Matthew R. McGrew currently own?
As insider, Mr. Matthew R. McGrew owns shares in 2 companies:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Danaher Corporation (DHR-PB) | Chief Financial Officer & Executive Vice President | 29,634 | $1,669.45 | $49,472,481 |
| Danaher Corporation (DHR) | Chief Financial Officer & Executive Vice President | 29,407 | $212.53 | $6,249,870 |
What does Danaher Corporation do?
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
What does Danaher Corporation do?
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Matthew R. McGrew insider trading
Danaher Corporation
Mr. Matthew R. McGrew has made 6 insider trades between 2019-2022, according to the Form 4 filled with the SEC. Most recently he sold 11,213 units of DHR-PB stock worth $3,083,160 on 11 Nov 2022.
The largest trade he's ever made was exercising 17,718 units of DHR-PB stock on 29 Apr 2019. As of 11 Nov 2022 he still owns at least 29,634 units of DHR-PB stock.
Danaher Corporation
Mr. Matthew R. McGrew has made 8 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently he sold 16,172 units of DHR stock worth $4,525,556 on 1 Aug 2024.
The largest trade he's ever made was exercising 46,377 units of DHR stock on 10 May 2024. As of 11 Nov 2022 he still owns at least 29,407 units of DHR stock.
Danaher key executives
Danaher Corporation executives and other stock owners filed with the SEC:
- Mr. Brian W. Ellis (58) Senior Vice President, Gen. Counsel & Chief Compliance Officer
- Mr. Joakim Weidemanis (56) Executive Vice President
- Mr. Matthew R. McGrew (53) Chief Financial Officer & Executive Vice President
- Mr. Rainer M. Blair (61) Pres, Chief Executive Officer & Director
- Ms. Angela S. Lalor (60) Senior Vice President of HR